Abstract:The issue of drug safety has received increasing attention in modern society. Estimating the frequency of drug side effects proves to be an effective approach to improving drug development safety. Clinical trials are the most widely used manner in the medical field, but their long duration and high labor costs are always challenging for researchers. Many drug side effect frequency prediction methods based on graph neural networks have also been proposed and achieved good results. However, most current mainstream methods extract feature information separately for drugs and side effects but fail to capture their interaction information, which seriously degenerates the final prediction performance. To solve this problem, we have proposed a network to explore the underlying relationship between drugs and the frequency of side effects by combining graph attention learning, cross attention interaction, and feature aggregation into a unified framework. In this network, we first use the graph attention mechanism to accomplish effective feature extraction for drugs and side effects, respectively. Then, by designing a cross-attention interaction module, the chemical characteristics of each atom of the drug and the correlation between the side effects are captured to gather information on the interaction between the drug and the side effects. Subsequently, we fully fuse graph attention features and interaction attention features by embedding a feature fusion module to obtain enhanced features that fuse drugs and side effects. Finally, the predicted frequency is obtained using matrix inner product operation. Experimental results on the SIDER dataset show that our proposed method achieves the best performance when compared to previous state-of-the-art methods in both warm start and cold start scenarios. We also conducted ablation experiments to demonstrate the effectiveness of different modules embedded in the network. The code, datasets, and materials are available at https://github.com/zixiaojin66/A-3Net-master . In addition, we construct a user-friendly web server for testing at: https://a3net666.streamlit.app/ .

MathEagle: Accurate prediction of drug-drug interaction events via multi-head attention and heterogeneous attribute graph learning

Accurate prediction of drug combination risk levels based on relational graph convolutional network and multi-head attention

Drug side effects prediction via cross attention learning and feature aggregation

Prediction of Drug-Drug Interaction Using an Attention-Based Graph Neural Network on Drug Molecular Graphs

An End-to-end Heterogeneous Graph Representation Learning-Based Framework for Drug-Target Interaction Prediction.

Drug-Drug Adverse Effect Prediction with Graph Co-Attention

DeepDDS: deep graph neural network with attention mechanism to predict synergistic drug combinations

DDI Prediction via Heterogeneous Graph Attention Networks

Integrating specific and common topologies of heterogeneous graphs and pairwise attributes for drug-related side effect prediction

KAMPNet: multi-source medical knowledge augmented medication prediction network with multi-level graph contrastive learning

MASMDDI: multi-layer adaptive soft-mask graph neural network for drug-drug interaction prediction

Prediction of Adverse Drug Reactions by Combining Biomedical Tripartite Network and Graph Representation Model.

Gorge: graph convolutional networks on heterogeneous multi-relational graphs for polypharmacy side effect prediction

A multi-task learning model for predicting drugs combination synergy by analyzing drug-drug interactions and integrated multi-view graph data

Drug-target interaction prediction by integrating heterogeneous information with mutual attention network

Drug Synergistic Combinations Predictions via Large-Scale Pre-Training and Graph Structure Learning

DrugE-Rank: Predicting Drug-Target Interactions by Learning to Rank

Detecting drug-drug interactions using artificial neural networks and classic graph similarity measures

Benchmarking Graph Learning for Drug-Drug Interaction Prediction

Heterogeneous Entity Representation for Medicinal Synergy Prediction

Hierarchical and dynamic graph attention network for drug-disease association prediction